News

You are here:

Home
News

Botanacor Opens New State-of-the-Art Lab Facility, Increasing Hemp & CBD Testing Capacity Ten Fold, as Demand for Its Services Grows

January 6, 2020

DENVER–(BUSINESS WIRE)–Botanacor Laboratories, the widely recognized leader in accredited testing of hemp biomass and hemp-derived CBD products, today announced that is has opened a new state-of-the-art laboratory testing facility in Denver. The new facility expands Botanacor Laboratories test volume capacity 10 fold over its previous operations. Botanacor is the first ISO/IEC Standard 17025 hemp-testing laboratory…

Details

Global Medical Marijuana Market 2018-2022| Evolving Opportunities with Aurora Cannabis and mCig | Technavio

January 6, 2020

LONDON–(BUSINESS WIRE)–Technavio has been monitoring the global medical marijuana market and the market is poised to grow by USD 25.25 billion during 2018-2022 at a CAGR of over 21% during the forecast period. Request Free Sample Pages Read the 115-page research report with TOC on “Medical Marijuana Market Analysis Report by Application (Chronic pain, Nausea,…

Details

Red Hot Chili Peppers, Dave Matthews Band, Stevie Nicks, Miley Cyrus, Khalid and Anderson .Paak & The Free Nationals to Headline BottleRock Napa Valley, May 22 – 24, 2020

January 6, 2020

NAPA, Calif.–(BUSINESS WIRE)– #BottleRock–BottleRock Napa Valley 2020, presented by JaM Cellars, announces its eighth annual festival lineup.

Columbia Care Has Triple-Digit Growth After Launch of Adult Use Sales in Illinois and Announces Partnerships with Local Social Equity Groups

January 6, 2020

NEW YORK–(BUSINESS WIRE)–Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest fully integrated operators in the global cannabis industry with licenses across the US and EU, today provided an update on its Illinois operations, including initial results from adult use cannabis sales at its Chicago dispensary…

Details

Columbia Care Selected by the Utah Department of Health to Receive One of 14 Medical Cannabis Pharmacy Licenses

January 6, 2020

NEW YORK–(BUSINESS WIRE)–Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest fully integrated operators in the global cannabis industry with licenses across the US and EU, today announced that it is one of 14 entities chosen by the Utah Department of Health (UDOH) to dispense medical…

Details

PAX Labs’ New Era ProTM Smart Vaporizer Elevates the Cannabis Experience

January 6, 2020

SAN FRANCISCO–(BUSINESS WIRE)–Today PAX Labs is unveiling its new Era ProTM, the world’s most sophisticated cannabis vaporizer device. Built with safety at its core, the Era Pro puts transparency and control directly into the hands of consumers, setting the gold standard for quality and delivering the best experience every single time. Smartest Vape Technology Era…

Details

REPEAT/Bophelo Partners with DNA Genetics in Lesotho

January 6, 2020

TORONTO–(BUSINESS WIRE)–Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that Bophelo Bioscience & Wellness (“Bophelo”) has signed a strategic alliance and seed purchase agreement with OG DNA Genetics Inc. (“DNA Genetics” or “DNA”), to give the Bophelo exclusive rights to develop new and existing DNA Genetics’…

Details

FSD Pharma to Begin Trading on the NASDAQ Capital Market Under Symbol ‘HUGE’ on January 9, 2020

January 6, 2020

TORONTO–(BUSINESS WIRE)–FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD Pharma” or the “Company”) today announced that its Class B Subordinate Voting Shares (the “Shares”) have been approved for listing on the NASDAQ Capital Market (“NASDAQ”) under the symbol ‘HUGE’. Trading on the NASDAQ is expected to commence at market open on Thursday, January…

Details

Xtraction Services Announces Sale of Non-Essential Equipment and Buy-Back of 13.4% of XS’ Outstanding Shares

January 6, 2020

LOS ANGELES–(BUSINESS WIRE)–Xtraction Services Holding Corp., (“Xtraction Services”, “XS” or the “Company“) (CSE:XS) a specialty finance company engaged in equipment leasing in the United States, announced today that effective December 31, 2019, the Company has completed a transaction (the “Transaction”) with a vendor and former partner and its staff (together, the “Vendors”), whereby all of…

Details

Alpine Immune Sciences Announces Poster Presentation at 2020 Crohn’s & Colitis Congress

January 6, 2020

SEATTLE–(BUSINESS WIRE)–Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune/inflammatory diseases, today announced the company will present a poster at the 2020 Crohn’s & Colitis Congress taking place January 23-25, 2020, in Austin, Texas. Details of the presentation are as follows: Presentation Title: ALPN-101, A…

Details

Can-Fite CEO Issues Letter to Shareholders

January 6, 2020

PETACH TIKVA, Israel–(BUSINESS WIRE)–Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, issued a Letter to Shareholders from the Company’s Chief Executive Officer, Pnina Fishman, Ph.D. Dear Can-Fite Shareholders, We made significant progress in our drug development programs during…

Details

Organigram to Report First Quarter Fiscal 2020 Results on January 14th, 2020 and Operational Update

January 3, 2020

MONCTON, New Brunswick–(BUSINESS WIRE)–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its first quarter fiscal 2020 ended November 30, 2019 on Tuesday, January 14th after market close. The Company will host a…

Details